Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

US STOCKS-Vaccine optimism propels Nasdaq to record high

Published 03/12/2020, 20:01
Updated 03/12/2020, 20:06
US STOCKS-Vaccine optimism propels Nasdaq to record high
US500
-
DJI
-
MQG
-
0RYA
-
TSLA
-
IXIC
-
SPNY
-
ZS
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Boeing jumps on Ryanair's 737 MAX jet orders
* Jobless claims fall after rising for two straight weeks
* Goldman Sachs raises Tesla to "buy"
* Indexes: Dow +0.42%, S&P 500 +0.04%, Nasdaq +0.36%

(Updates with afternoon trade)
By Noel Randewich
Dec 3 (Reuters) - The Nasdaq Composite .IXIC hit an
all-time high on Thursday as investors stayed focused on a
COVID-19 vaccine and looked beyond bleak economic data, while
Boeing Co BA.N lifted the Dow Jones Industrial Average.
The S&P 500 .SPX bounced between a slight loss and a
slight gain after hitting a record high.
Boeing jumped over 7% after budget airline Ryanair RYA.I
ordered 75 additional 737 MAX jets with a list price of $9
billion, throwing a commercial lifeline to the embattled U.S.
planemaker. Tesla Inc surged TSLA.O 5% and drove the Nasdaq higher
after Goldman Sachs upgraded the stock to "buy" in the run-up to
the electric car maker's addition to the S&P 500. Data showed the number of Americans filing first-time claims
for jobless benefits fell last week, but remained
extraordinarily high at 712,000, while a separate survey showed
U.S. services industry activity slowed to a six-month low in
November. "I don't think we will see those numbers start to get back
to normal until we start to see a rollout of a vaccine," said
Sal Bruno, chief investment officer at IndexIQ. "The market is
discounting that and saying we are looking forward to the first
or second quarter and a rollout of the vaccine to the general
population."
U.S. Senate Majority Leader Mitch McConnell cited some
positive movement in congressional efforts to reach a compromise
on a new coronavirus aid bill but gave no hints on when such a
deal could be struck. Progress in developing a working COVID-19 vaccine before the
end of the year has driven the Wall Street's main indexes to
record levels in recent days. Despite the economic destruction
caused by the pandemic, the S&P 500 has gained 14% in 2020.
The Dow Jones Industrial Average .DJI was up 0.42% at
30,008.19 points, while the S&P 500 .SPX gained 0.04% to
3,670.36.
The Nasdaq Composite .IXIC added 0.36% to 12,394.21.
Five of the 11 major S&P 500 sector indexes rose, energy
.SPNY up 2% and leading gains.
Ongoing vaccine optimism helped lift the S&P 1500 airlines
index .SPCOMAIR 6%. Cruise operators Carnival Corp CCL.N
jumped 10% and Norwegian Cruise Line Holdings Ltd NCLH.N
surged 9%.
Cloud-security provider Zscaler Inc ZS.O surged 23% after
it reported better-than-expected first-quarter revenue and
adjusted profit.
Waddell & Reed Financial WDR.N surged 50%, extending gains
from the previous session, after Australia's Macquarie Group
MQG.AX announced a deal to buy the wealth manager for $1.7
billion. Advancing issues outnumbered decliners on the NYSE by a
2.59-to-1 ratio; on Nasdaq, a 1.95-to-1 ratio favored advancers.
The S&P 500 posted 32 new 52-week highs and no new lows; the
Nasdaq Composite recorded 154 new highs and six new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.